Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Expenses
Research and development	$ 2,337	$ 1,309
General and administrative	5,071	3,948
Depreciation and amortization	148	115
Total operating expenses and loss from operations	7,556	5,372
Other (income) expenses
Interest income	(1,833)	0
Interest expense, net of capitalized interest	0	280
Change in fair value of derivatives	834	391
Change in fair value of warrants liability	1,774	48,109
Change in fair value of earnout liability	(15,227)	0
Other income, net	(450)	(581)
Total other (income) expenses, net	(14,902)	48,199
Net income (loss)	7,346	(53,571)
Other comprehensive income (loss)
Unrealized (loss) on marketable securities	(4,575)	0
Foreign currency translation adjustment, net of tax	885	466
Total comprehensive income (loss)	$ 3,656	$ (53,105)
Net income (loss) per share, basic (in dollars per share)	$ 0.05	$ (0.86)
Net income (loss) per share, diluted (in dollars per share)	$ 0.05	$ (0.86)
Weighted-average common shares outstanding, basic (in shares)	136,825,016	62,652,947
Weighted-average common shares outstanding, diluted (in shares)	141,732,403	62,652,947